Developing the A-FLUX Reducer System, a coronary sinus implant that narrows the vessel to raise myocardial perfusion in coronary microvascular dysfunction. The SERRA-I early feasibility study plans 30 subjects across six sites.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
Unsubscribe anytime. We never sell the list.
By registering, you agree to receive communications from us. Your information may also be shared with sponsors and partners identified on this Site for relevant industry communications. You may unsubscribe at any time. See our Privacy Policy.